Dr. Azad Kumar Singh (2025) “IMPACT OF TYPE 2 DIABETES MELLITUS ON RIFAMPICIN PHARMACOKINETICS AND BIOCHEMICAL PATHWAYS IN PULMONARY TUBERCULOSIS PATIENTS”, Journal of Population Therapeutics and Clinical Pharmacology, 32(7), pp. 1149–1153. doi:10.53555/gcv48408.